Kieffer Tara Lynn
Chief Product Strategy Officer
Kieffer Tara Lynn has filed 3 SEC Form 4 filings (5 transaction rows) across 1 company, with disclosures dating back to 2025. 3 of those filings fall inside the rolling window. Most recent filing: Feb 13, 2026.
On the most recent filing, Kieffer Tara Lynn is listed as Chief Product Strategy Officer at ENANTA PHARMACEUTICALS INC. Inside the rolling window, Kieffer Tara Lynn reported no open-market purchases and 1 open-market sale totaling $30K in ENTA.
Companies traded
Other insiders at ENTA
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$30K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Kieffer Tara Lynn made?
Kieffer Tara Lynn has filed 3 SEC Form 4 filings (5 transaction rows) across 1 company since 2025.
Which companies does Kieffer Tara Lynn trade?
Kieffer Tara Lynn has filed SEC Form 4 disclosures for 1 company, including ENTA.
When was Kieffer Tara Lynn's most recent SEC Form 4 filing?
Kieffer Tara Lynn's most recent SEC Form 4 filing on Tracefour is dated Feb 13, 2026.
What is Kieffer Tara Lynn's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Kieffer Tara Lynn is listed as Chief Product Strategy Officer.
What is Kieffer Tara Lynn's total buy and sell value in the current window?
Inside the rolling retention window, Kieffer Tara Lynn bought $0 and sold $30K based on SEC Form 4 filings.
What was Kieffer Tara Lynn's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 2,106 ENTA shares on 2025-12-05, worth $30K, per SEC Form 4 filings.